Celltrion, Inc. (KRX:068270)
South Korea · Delayed Price · Currency is KRW 171,400
-5,100 (-2.89%)
At close: Jun 5, 2026
Celltrion Market Cap
Celltrion has a market cap or net worth of 37.72 trillion as of June 5, 2026. Its market cap has increased by 10.99% in one year.
Market Cap
37.72T
Enterprise Value
40.31T
Revenue
4.47T
Ranking
n/a
PE Ratio
31.25
Stock Price
171,400.00
Market Cap Chart
Since August 20, 2008, Celltrion's market cap has increased from 103.80B to 37.72T, an increase of 36,237.96%. That is a compound annual growth rate of 39.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 4, 2026 | 38.84T | -1.92% |
| Dec 30, 2025 | 39.60T | -1.89% |
| Dec 30, 2024 | 40.37T | 44.32% |
| Dec 28, 2023 | 27.97T | 21.61% |
| Dec 29, 2022 | 23.00T | -16.64% |
| Dec 30, 2021 | 27.59T | -43.68% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 62.49T |
| ALTEOGEN | 18.54T |
| Samsung Epis Holdings | 11.36T |
| Kolon TissueGene | 9.28T |
| HLB Co., Ltd. | 6.98T |
| SK Biopharmaceuticals | 6.90T |
| Peptron | 6.21T |
| LigaChem Biosciences | 5.37T |